The Complexity of the Phospholipid Binding Protein Annexin V

• References

• 1 Bohn H. Placental and pregnancy proteins. In: Carcinoembryonic proteins. Lehman FG. ed. Vol 1 Amsterdam: Elsevier, North Holland Biomedical Press; 1979. pp 289-299
• 2 Reutelingsperger CP M, Homstra G, Hemker HC. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur J Biochem 1985; 151: 625-629
• 3 Iwasaki A, Suda M, Nakao H, Nagoya T, Saino Y, Arai K, Mizoguchi T, Sato F, Yoshizaki H, Hirata M, Miyata T, Shidara Y, Murata M, Maki M. Structure and expression of cDNA for an inhibitor of blood coagulation isolated from human placenta: a new lipocortin-like protein. J Biochem Tokyo 1997; 102: 1261-1273
• 4 Kaplan R, Jaye M, Burgess WH, Schlaepfer DD, Haigler HT. Cloning and expression of cDNA for human endonexin II, a Ca²⁺and phospholipid binding protein. J Biol Chem 1988; 263: 8037-8043
• 5 Funakoshi T, Heimark RL, Hendrickson LE, McMullen BA, Fujikawa K. Human placental anticoagulant protein: isolation and characterization. Biochemistry 1987; a 26: 5572-5578
• 6 Pepinsky RB, Tizard R, Mattaliano RJ, Sinclair LK, Miller GT, Browning JL, Chow EP, Burne C, Huang K-S, Pratt D, Wachter L, Hession C, Frey AZ, Wallner BP. Five distinct calcium and phospholipid binding proteins share homology with lipocortin I. J Biol Chem 1988; 263: 10799-10811
• 7 Kaetzel MA, Hazarika P, Dedman JR. Differential tissue expression of three 35 kDa Annexin calcium-dependent phospholipid binding proteins. J Biol Chem 1989; 264: 14463-14470
• 8 Mollenhauer J, von der Mark K. Isolation and characterization of a collagen-binding glycoprotein from chondrocyte membranes. EMBO J 1993; 2: 45-50
• 9 Funakoshi T, Hendrickson LE, McMullen BA, Fujikawa K. Primary structure of human placental anticoagulant protein. Biochemistry 1987; b 26: 8087-8092
• 10 Grundmann U, Abel KJ, Bohn H, Löbermann H, Lottspeich F, Küpper H. Characterization of cDNA encoding human placental anticoagulant protein (PP4): Homology with the lipocortin family. Proc Natl Acad Sci USA 1988; 85: 3708-3712
• 11 Maurer-Fogy I, Reutelingsperger CP M, Pieters J, Bodo G, Stratowa C, Hauptmann R. Cloning and expression of cDNA for human vascular anticoagulant, a Ca²⁺-dependent phospholipid-binding protein. Eur J Biochem 1998; 174: 585-592
• 12 Geisow MJ, Fritsche U, Hexham JM, Dash B, Johnson T. A consensus amino acid sequence repeat in Torpedo and mammalian Ca²⁺-dependent membrane-binding proteins. Nature 1996; 320: 636-638
• 13 Römisch J, Grote M, Weithmann KU, Heimburger N, Amann E. Annexin proteins PP4 and PP4-X: comparative characterization of biological activities of placental and recombinant proteins. Biochem J 1990; a 272: 223-229
• 14 Taylor WR, Geisow MJ. Predicted structure for the calcium-dependent membrane binding proteins p35, p36 and p32. Protein Eng 1987; 1: 183-187
• 15 Brisson A, Mosser G, Huber R. Structure of soluble and membrane-bound human Annexin V. J Mol Biol 1991; 220: 199-203
• 16 Huber R, Römisch J, Paques EP. The crystal and molecular structure of human Annexin V, an anticoagulant protein that binds to calcium and membranes. EMBO J 1990; a 9: 3867-3874
• 17 Huber R, Schneider M, Mayr I, Römisch J, Paques EP. The calcium binding sites in human Annexin V by crystal structure analysis at 2.0 Å resolution. FEBS lett 1990; b 275: 15-21
• 18 Huber R, Berendes R, Burger A, Schneider M, Karshikov A, Luecke H, Römisch J, Paques E. Crystal and molecular structure of human Annexin V after refinement. J Mol Biol 1992; 223: 683-704
• 19 Lewit-Bentley A, Doublié S, Fourme R, Bodo G. Crystallization and preliminary X-ray studies of human vascular anticoagulant protein. J Mol Biol 1999; 210: 875-876
• 20 Lewit-Bentley A, Morera S, Huber R, Bodo G. The effect of metal binding on the structure of Annexin V and implications for membrane binding. Eur J Biochem 1992; 210: 73-77
• 21 Sopkova J, Rennouard M, Lewit-Bentley A. The crystal structure of a new high-calcium form of Annexin V. J Mol Biol 1993; 234: 816-825
• 22 Lewit-Bentley A, Bentley GA, Favier B, L’Hermite GL, Renouard M. The interaction of metal ions with Annexin V: a crystallographic study. FEBS lett 1994; 345: 38-42
• 23 Concha NO, Head JF, Kaetzel MA, Dedman JR, Seaton BA. Annexin V forms calcium-dependent trimeric units on phospholipids vesicles. FEBS lett 1992; 314: 159-162
• 24 Hauptmann R, Reutelingsperger CP M. Molecular biology and biochemistry of Annexins V and VIII. In: Research Monograph “The Annexins”. Moss S. ed. Londen-Chapel Hill; 1993: 139-152
• 25 Meers P. Location of tryptophans in membrane-bound Annexins. Biochemistry 1990; 29: 3325-3330
• 26 Meers P, Mealy T. Calcium-dependent Annexin V binding to phospholipids: stoichiometry, specificity, and role of negative charge. Biochemistry 1993; 32: 11711-11721
• 27 Schlaepfer DD, Mehlman T, Burgess WH, Haigler HT. Structural and functional characterization of endonexin a calcium- and phospholipid binding protein. Proc Natl Acad Sci USA 1987; 84: 6078-6082
• 28 Sopkova J, Galley J, Vincent M, Pancoska P, Lewit-Bentley A. The dynamic behavior of Annexin V as a function of calcium ion binding: a circular dichroism, UV absorption, and steady-state and time-resolved fluorescence study. Biochemistry 1994; 33: 4490-4499
• 29 Andree HA M, Reutelingsperger CP M, Hauptmann R, Hemker HC, Hermens WT, Willems GM. Binding of vascular anticoagulant (VACa) to planar phospholipid bilayers. J Biol Chem 1990; 265: 4923-4928
• 30 Meers P, Daleke D, Hong K, Papahadjopoulos D. Interactions of Annexins with membrane phospholipids. Biochemistry 1991; 30: 2903-2908
• 31 Tait JF, Gibson D, Fujikawa K. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem 1999; 264: 7944-7949
• 32 Meers P, Mealy T. Phospholipid determinants for Annexin V binding sites and the role of tryptophan 187. Biochemistry 1994; 33: 5829-5837
• 33 Blackwood RA, Ernst JD. Characterization of Ca²⁺-dependent phospholipid binding, vesicle aggregation and membrane fusion by Annexins. Biochem J 1990; 266: 195-200
• 34 Pigault C, Follenius-Wund A, Schmutz M, Freyssinet J-M, Brisson A. Formation of two-dimensional arrays of Annexin V on phosphatidyl- serine-containing liposomes. J Mol Biol 1994; 236: 199-208
• 35 Andree HA M, Stuart MC A, Hermens WT h, Reutelingsperger CP M, Hemker HC, Frederik PM, Willems GM. Clustering of lipid-bound Annexin V may explain its anticoagulant effect. J Biol Chem 1992; 267: 17907-17912
• 36 Creutz CE. The Annexins and exocytosis. Science 1992; 258: 924-931
• 37 Raynal P, Pollard HB. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid binding proteins. Biochim Biophys Acta 1994; 1197: 63-93
• 38 Andree HA M, Willems GM, Hauptmann R, Maurer-Fogy I, Stuart MC A, Hermens WTh, Frederik PM, Reutelingsperger CP M. Aggregation of phospholipid vesicles by a chimeric protein with the N-terminus of Annexin I and the core of Annexin V. Biochemistry 1993; 32: 4634-4640
• 39 Ernst JD, Hoye E, Blackwood RA, Mok TL. Identification of a domain that mediates vesicle aggregation reveals functional diversity of Annexin repeats. J Biol Chem 1991; 266: 6670-6673
• 40 Hoekstra D, Buist-Arkema R, Klappe K, Reutelingsperger CP M. Interaction of Annexins with membranes: the N-terminus as a governing parameter as revealed with chimeric Annexin. Biochemistry 1993; 32: 14194-14202
• 41 Oshry L, Meers P, Mealy T, Tauber AI. Annexin-mediated membrane fusion of human neutrophil plasma membranes and phospholipid vesicles. Biochim Biophys Acta 1991; 1066: 239-244
• 42 Sun J, Bird P, Salem HH. Interaction of Annexin V and platelets: effects on platelet function and proteinS binding. Thromb Res 1993; b 69: 289-296
• 43 Thiagarajan P, Tait JF. Binding of Annexin V/Placental anticoagulant protein I to platelets. J Biol Chem 1990; 265: 17420-17423
• 44 Tait JF, Gibson D. Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of Annexin V binding. J Lab Clin Med 1994; 123: 741-748
• 45 Rao LV M, Tait J, Hoang AD. Binding of Annexin V to a human ovarian carcinoma cell line (OC-2008): contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity. Thromb Res 1992; 67: 517-531
• 46 Van Heerde WL, Poort S, van’t Veer C, Reutelingsperger CP M, de Groot PhG. Binding of recombinant Annexin V to endothelial cells: effect of Annexin V binding on endothelial-cell-mediated thrombin formation. Biochemical J 1994; a 302: 305-312
• 47 Van Heerde WL, Sakariassen KS, Hemker HC, Sixma JJ, Reutelingsperger CP M, de Groot PhG. Annexin V inhibits the procoagulant activity of matrices of TNF-stimulated endothelium under blood flow conditions. Arterioscler Thromb 1994; b 14: 824-830
• 48 Brinkman H-JM, Mertens K, Holthuis J, Zwart-Huinink LA, Grijm K, Van Mourik JA. The activation of human blood coagulation factor X on the surface of endothelial cells: a comparison with various vascular cells, platelets and monocytes. Br J Haemat 1994; 87: 332-342
• 49 Homburg CH E, de Haas M, von dem Borne AE G Kr, Verhoeven AJ, Reutelingsperger CP M, Roos D. Human neutrophils lose their surface Fc_RIII and acquire Annexin V binding sites during apoptosis in vitro. 1994 in press
• 50 Giambanco I, Pula G, Bianchi R, Donato R. Interaction of two brain Annexins, CaBP33 and CaBP37, with membrane-skeleton proteins. FEBS LETT 1990; 267: 171-175
• 51 Kirsch T, Pfäffle M. Selective binding of anchorin CII (Annexin V) to type II and X collagen and to chondrocalcin (C-propeptide of type II collagen). FEBS LETT 1992; 310: 143-147
• 52 Wu LN Y, Genge BR, Lloyd GC, Wuthier RE. Collagen-binding protein in collagenase-released matrix vesicles from cartilage. J Biol Chem 1991; 266: 1195-1203
• 53 Reutelingsperger CP M, Kop JM M, Hornstra G, Hemker HC. Purification and characterization of a novel protein from bovine aorta that inhibits coagulation. EurJ Biochem 1988; 173: 171-178
• 54 Almus FE, Rao VM, Rapaport SI. Regulation of factor VIIa/tissue factor functional activity in an umbilical vein model. Arterioscler Thromb 1993; 13: 105-111
• 55 Boustead C, Walker JH, Geisow MJ. Isolation and characterization of two novel calcium-dependent phospholipid-binding proteins from bovine lung. FEBS LETT 1998; 233: 233-238
• 56 Khanna NC, Helwig ED, Ikebuchi NW, Fitzpatrick S, Bajwa R, Waisman DM. Purification and characterization of Annexin proteins from bovine lung. Biochemistry 1990; 29: 4852-4862
• 57 Ahn NG, Teller DC, Bienkowski MJ, McMullen BA, Lipkin EW, de Haën C. Sedimentation equilibrium analysis of five lipocortin-related phospholipase A₂inhibitors from human placenta. J Biol Chem 1988; 263: 18657-18663
• 58 Buhl W-J, Garcia MT, Zipfel M, Schiebler W, Gehring U. A series of Annexins from human placenta and their characterization by use of an endogenous phospholipase A₂ . Eur J Cell Biol 1991; 56: 381-390
• 59 Römisch J, Heimburger N. Purification and characterization of six Annexins from human placenta. Biol Chem Hoppe-Seyler 1990; 371: 383-388
• 60 Tait JF, Sakata M, McMullen BA, Miao CH, Funakoshi T, Hendrickson LE, Fujikawa K. Placental anticoagulant proteins: isolation and comparative characterization of four members of the lipocortin family. Biochemistry 1988; 27: 6268-6276
• 61 Kobayashi R, Tashima Y. Identification and partial separation of three distinct 32-kDa calcium/phospholipid-regulated proteins from bovine spleen. Biochem Biophys Res Comm 1989; 162: 15-23
• 62 Reutelingsperger CP M, van Heerde WL, Hauptmann R, Maassen C, van Gool RG J, de Leeuw P, Tiebosch A. Differential tissue expression of Annexin VIII in human. FEBS LETT 1994; 349: 120-124
• 63 Seaton BA, Head JF, Kaetzel MA, Dedman JR. Purification, crystallization, and preliminary X-ray diffraction analysis of rat kidney Annexin V, a calcium-dependent phospholipid-binding protein. J Biol Chem 1990; 265: 4567-4569
• 64 Woolgar JA, Boustead CM, Walker JH. Characterization of Annexins in mammalian brain. J Neurochem 1990; 54: 62-71
• 65 Learmonth MP, Howell SA, Harris AC M, Amess B, Patel Y, Giambanco I, Bianchi R, Pula G, Ceccarelli P, Doanto R, Green BN, Aitken A. Novel isoforms of CaBP33/37 (Annexin V) from mammalian brain: structural and phosphorylation differences that suggest distinct biological roles. Bio-chim Biophys Acta 1992; 1160: 76-83
• 66 Kobayashi R, Nakayama R, Ohta A, Sakai F, Sakuragi S, Tashima Y. Identification of the 32 kDa components of bovine lens EDTA-extractable protein as endonexins I and II. Biochem J 1990; b 266: 505-511
• 67 Kobayashi R, Hidaka H, Tashima Y. Purification, characterization, and partial sequence analysis of 32-kDa Calcimedin from chicken gizzard. Arch Biochem Biophys 1990; a 277: 203-210
• 68 Christmas P, Callaway J, Fallon J, Jones J, Haigler HT. Selective secretion of Annexin 1, a protein without a signal sequence, by the human prostate gland. J Biol Chem 1991; 266: 2499-2507
• 69 Flaherty MJ, West S, Heimark RL, Fujikawa K, Tait JF. Placental anticoagulant protein 1: Measurement in extracellular fluids and cells of the hemostatic system. J Lab Clin Med 1990; 115: 174-181
• 70 Römisch J, Schüler E, Bastian B, Bürger T, Dunkel F-G, Schwinn A, Hartmann AA, Pâques E-P. Annexin I to VI: quantitative determination in different human cell types and in plasma after myocardial infarction. Blood Coagulation and Fibrinolysis 1992; 3: 11-17
• 71 Takehara K, Uchida S, Marumoto N, Asawa T, Osugi S, Kurusu S, Hashimoto I, Kawaminami M. Secretion of recombinant rat Annexin 5 by insect cells in a baculovirus expression system. Biochem Biophys Res Comm 1994; 200: 1421-1427
• 72 Murphy CT, Peers SH, Forder RA, Flower RJ, Carey F, Westwick J. Evidence for the presence and location of Annexins in human platelets. Biochem Biophys Res Comm 1992; 189: 1739-1746
• 73 Fujimagari M, Williamson PL, Schlegel RA. Ca²⁺-dependent membrane- binding proteins in normal erythrocytes and erythrocytes from patients with chronic myelogenous leukemia. Blood 1990; 75: 1337-1345
• 74 Rothhut B, Coméra C, Cortial S, Haumont P-Y, Diep Le KH, Cavadore J-C, Conrad J, Russo-Marie F, Lederer F. A 32 kDa lipocortin from human mononuclear cells appears to be identical with the placental inhibitor of blood coagulation. Biochem J 1989; 263: 929-935
• 75 Pfaffle M, Ruggiero F, Hofman H, Fernandez MP, Selmin O, Yamada Y, Garrone R, von der Mark K. Biosynthesis, secretion and extracellular localization of anchorin CII, a collagen-binding protein of the calpactin family. EMBO J 1988; 7: 2335-2342
• 76 Hertogs K, Leenders WP J, Depla E, de Bruin WC C, Meheus L, Raymackers J, Moshage H, Yap SH, Endonexin II. present on human liver plasma membranes, is a specific binding protein of small hepatitis B virus (HBV) envelope protein. Virology 1993; 197: 549-557
• 77 Iwasaki A, Suda M, Watanabe M, Nakao H, Hattori Y, Nagoya T, Saino Y, Shidara Y, Maki M. Structure and expression of cDNA for Calpho- bindin II, a human placental coagulation inhibitor. J Biochem 1989; 106: 43-49
• 78 Römisch J, Schorlemmer U, Fickenscher K, Pâques E-P, Heimburger N. Anticoagulant properties of placenta protein 4 (Annexin V). Thromb Res 1990; b 60: 355-366
• 79 Hauptmann R, Maurer-Fogy I, Krystek E, Bodo G, Andree H, Reutelingsperger CP M. Vascular anticoagulant β: a novel human Ca²⁺/phospholipid binding protein that inhibits coagulation and phospholipase A₂activity. Eur J Biochem 1989; 185: 63-171
• 80 Kondo S, Noguchi M, Funakoshi T, Fujikawa K, Kisiel W. Inhibition of human factor VIIa-tissue factor activity by placental anticoagulant protein. Thromb Res 1997; 48: 449-459
• 81 Ravanat C, Archipoff G, Beretz A, Freund G, Cazenave JP, Freyssinet JM. Use of Annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells. Biochem J 1992; 282: 7-13
• 82 Andree HA M, Contino PB, Repke D, Gentry R, Nemerson Y. Transport rate limited catalysis on macroscopic surface: the activation of factor X in a continuous flow enzyme reactor. Biochemistry 1994; 33: 4368-4374
• 83 Sun J, Bird P, Salem HH. Effects of Annexin V on the activity of the anticoagulant proteins C and S. Thromb Res 1993; a 69: 279-287
• 84 Römisch J, Pacques E. Annexins: calcium-binding proteins of multi-functional importance. Med Microbiol Immunol 1991; 180: 109-126
• 85 Van Ryn-McKenna J, Merk H, Müller TH, Buchanan MR, Eisert WG. The effects of heparin and Annexin V on fibrin accretion after injury in the jugular veins of rabbits. Thromb Haemost 1993; 69: 227-230
• 86 Kirchhofer D, Tschopp TB, Hadvary P, Baumgartner HR. Endothelial cells stimulated with tumor necrosis factor-Ó express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. J Clin Invest 1994; 93: 2073-2083
• 87 Funakoshi T, Abe M, Sakata M, Shoji S, Kubota Y, Shimada H, Kojima S. Novel anticoagulant peptides from the functional site of human placental anticoagulant protein. Biochem Int 1991; 24: 173-180
• 88 Davidson FF, Dennis EA, Powell M, Glenney JR. Inhibition of phospholipase A₂by “lipocortins” and calpactins. J Biol Chem 1987; 262: 1698-1705
• 89 Van Bilsen M, Reutelingsperger CP M, Willemsen PH, Reneman RS, van der Vusse G. Annexin in cardiac tissue: cellular localisation and the effect on phospholipase activity. Mol Cell Biochem 1992; 116: 95-101
• 90 Schlaepfer DD, Jones J, Haigler HT. Inhibition of protein kinase C by Annexin V. Biochemistry 1992; b 31: 1886-1891
• 91 Raynal P, Hullin F, Ragab-Thomas JM F, Fauvel J, Chap H. Annexin V as a potential regulator of Annexin 1 phosphorylation by protein kinase C. Biochem J 1993; 292: 759-765
• 92 Demange P, Voges D, Benz J, Liemann S, Göttig P, Berendes R, Burger A, Huber R. Annexin V: the key to understanding ion selectivity and voltage regulation. Trends in Biochemical Sciences 1994; 19: 272-276
• 93 Swairjo MA, Seaton BA. Annexin structure and membrane interactions: a molecular perspective. Annu Rev Biophys Biomol Struct 1994; 23: 193-213
• 94 Burns AL, Magendzo K, Shirvan A, Srivastava M, Rojas E, Alyani MR, Pollard HB. Calcium channel activity of purified human synexin and structure of the human synexin gene. Proc Natl Acad Sci USA 1989; 86: 3798-3802
• 95 Rojas E, Pollard HB, Haigler HT, Parra C, Bums AL. Calcium-activated endonexin II forms calcium channels across acidic phospholipid bilayer membranes. J Biol Chem 1990; 265: 21207-21215
• 96 Berendes R, Burger A, Voges D, Demange P, Huber R. Calcium influx through Annexin V ion channels into large unilamellar vesicles measured with fura-2. FEBS LETT 1993; 317: 131-134
• 97 Burger A, Voges D, Demange P, Ruiz Perez C, Huber R, Berendes R. Structural and electrophysiological analysis of Annexin V mutants. J Mol Biol 1994; 237: 479-499
• 98 Voges D, Berendes R, Burger A, Denange P, Baumeister W, Huber R. Three-dimensional structure of membrane-bound Annexin V: a correlative electron microscopy-X-ray crystallography study. J Mol Biol 1994; 238: 199-213
• 99 Schlaepfer DD, Haigler HT. Expression of Annexins as a function of cellular growth state. J Cell Biol 1990; 111: 229-238
• 100 Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and non- SLE disorders. Ann Int Med 1990; 112: 682-698
• 101 Rand JH, Wu X-X, Nemerson Y, Lockwood CJ. Deficiency of Annexin V (placental anticoagulant protein-I) on the surface of placental villi of women with antiphospholipid antibodies and recurrent abortion. Thromb Haemost 1993; b 69: 953 (abstract)
• 102 de Groot PhG, Oosting J, Derksen RH W M. Antiphospholipid antibodies: Specificity and pathophysiology. Balliere’s Clin Haematol 1993; 6: 691-709
• 103 Matsuda J, Saitoh N, Gohchi K, Gotoh M, Tsukamoto W. Antiannexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. Am J Hematol 1994; 47: 56-58